Filing Details

Accession Number:
0001127602-13-003200
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-30 17:11:17
Reporting Period:
2013-01-28
Filing Date:
2013-01-30
Accepted Time:
2013-01-30 17:11:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219016 W Michael Bonney 65 Hayden Avenue
Lexington MA 02421
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-28 40,352 $8.23 182,852 No 4 M Direct
Common Stock Disposition 2013-01-28 40,352 $43.09 142,500 No 4 S Direct
Common Stock Acquisiton 2013-01-29 65,100 $8.23 207,600 No 4 M Direct
Common Stock Disposition 2013-01-29 65,100 $42.85 142,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2013-01-28 40,352 $0.00 40,352 $8.23
Common Stock Stock Options (Right to Buy) Disposition 2013-01-29 65,100 $0.00 65,100 $8.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,100 2003-05-26 2013-02-26 No 4 M Direct
0 2003-05-26 2013-02-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,277 Indirect 401(k) Plan
Footnotes
  1. Sold pursuant to a 10(b)5-1 Plan
  2. This transaction was executed in multiple trades at prices ranging from $42.74 to $43.43. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $42.66 to $43.098. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  4. Option vests 6.25% quarterly over a four-year period.